Navigation Links
Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-Cell Vaccines Against House Dust Mite and Cat Allergies
Date:1/19/2010

l regulatory and supply chain benefits. The short peptides utilised in Circassia's vaccines are manufactured chemically, in contrast to existing allergen immunotherapies, which are purified from natural sources. Circassia's approach applies the chemistry, manufacturing and control standards associated with conventional pharmaceuticals to its allergy T-cell vaccines. This fits with changes in the European regulatory environment, where authorities are increasingly treating allergen immunotherapies as pharmaceutical products, and requiring elimination of the batch-to-batch potency variability that is an intrinsic feature of many current treatments.

About Circassia

Circassia has a highly experienced management team with a proven track record in product development and commercialisation. Having successfully completed three fundraising rounds the company is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Invesco Perpetual, Goldman Sachs and Lansdowne Partners.

    For more information please visit http://www.circassia.co.uk.

    Contacts
    Steve Harris                             Rob Budge
    CEO                                      RJB Communications
    Circassia                                Tel: +44(0)1865-760969
    Tel: +44(0)1865-784574                   Mobile: +44(0)7710-741241


SOURCE Circassia Ltd


'/>"/>
SOURCE Circassia Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round
2. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
3. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
4. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
5. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
6. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
7. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
8. Applied Seals North America Extends Global Network With Addition of Distributor in Europe
9. Lincare Holdings Inc. Extends Terms of Employment Agreements with Executive Officers
10. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
11. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... BRUNSWICK, N.J., Nov. 28, 2011  Johnson & Johnson (NYSE: ... Annual Health Care Conference on Tuesday, Nov. 29 th at ... Chairman, Ethicon will present in a session scheduled at 8:00 a.m. ... investors and other interested parties by accessing the Johnson & Johnson ...
... 2011 The National Association of Drug Diversion ... cooperation between law enforcement, healthcare professionals, state regulatory ... investigation of drug diversion – today applauded the ... Exchange (NPLEx) demonstrating the real-time, stop-sale system in ...
Cached Medicine Technology:Alabama Stop-Sale System Blocks Illegal Sales & Allows Legal Ones 2
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... Ill. One of the most popular vaccine brands ... And doctors may be overlooking some cost factors when ... a more expensive option, according to a new study ... vaccines to administer can be driven by numerous factors," ... and a professor of computer science and of mathematics ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... older Americans suffer from depression, often brought on by ... a project that followed the lives of thousands ... that Internet use among the elderly can reduce the ... "That,s a very strong effect," said Shelia Cotten, a ... media who led the project. "And it all has ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit organization ... published a comprehensive review today examining the current state ... The review calls for improved global surveillance strategies to ... recent outbreak of Ebola in West Africa that has ... of Guinea and Liberia. According to the World ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Internet use can help ward off depression among elderly 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3
... 23, 2009) Postpartum depression is a seriousand often ... mothers. Some of the causes might include personal history ... financial or emotional support. Left untreated, it can have ... on her child,s development. , In the ...
... suggest that men discuss use of medicines such as Propecia ... Healthy men with no signs of prostate cancer may wish ... could further reduce their risk for the disease, new guidelines ... the American Urological Association have issued new guidelines recommending that ...
... Medical Center treated its first behavioral health patient yesterday with ... is the first DoD facility to use this technology and ... others such as Brown University , Columbia University ... TMS Therapy device was approved by the FDA last October ...
... , What A Congressional forum organized by the Leadership Conference ... last two decades more than a half, ... healthcare coverage. Critical analysis of these models is ... reform debate. The February 25 forum, ...
... their jobs and health insurance, they,re turning to federal ... 24 (HealthDay News) -- Although millions of Americans have ... during the current recession, health care spending in the ... increase in 2009. , That,s the surprising conclusion of ...
... TO SEE INFLUENZA AS A CREDIBLE BUSINESS THREATDETROIT, Feb. ... lost wages every year, and recent studies found that ... about 200 million days of restricted activity, are due ... low, especially among working adults. In fact, adults between ...
Cached Medicine News:Health News:Diabetes a risk factor for postpartum depression 2Health News:Drugs May Help Healthy Men Lower Prostate Cancer Risk 2Health News:Walter Reed First Military Hospital to Use Transcranial Magnetic Stimulation to Treat Depression 2Health News:National Lessons from State Health Reform: The Massachusetts Case Study 2Health News:Recession Scrambling Health Spending in U.S. 2Health News:Recession Scrambling Health Spending in U.S. 3Health News:Recession Scrambling Health Spending in U.S. 4Health News:Influenza Infection Costs Employees Billions Each Year; Working Adults Largest Group Not Immunized Annually 2Health News:Influenza Infection Costs Employees Billions Each Year; Working Adults Largest Group Not Immunized Annually 3Health News:Influenza Infection Costs Employees Billions Each Year; Working Adults Largest Group Not Immunized Annually 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: